Introduced
by
To impose a new coverage mandate that would require health insurance policies that already include coverage for prescription drugs to also pay for “treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome”.
Referred to the Committee on Rules and Competitveness
